Nicotine vaccine - Tria Bioscience
Latest Information Update: 06 Sep 2023
At a glance
- Originator TRIA Bioscience
- Class Drug withdrawal therapies; Smoking cessation therapies; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Smoking withdrawal
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Smoking withdrawal in USA (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Smoking-withdrawal in USA
- 14 Jul 2016 Preclinical trials in Smoking withdrawal in USA (unspecified route)